Search Results - "Waldner, Anne"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy by Duval, Xavier, Journot, Valérie, Leport, Catherine, Chêne, Geneviève, Dupon, Michel, Cuzin, Lise, May, Thierry, Morlat, Philippe, Waldner, Anne, Salamon, Roger, Raffi, François

    Published in Clinical infectious diseases (15-07-2004)
    “…Risk factors associated with the occurrence of protease inhibitor (PI)—related severe and serious adverse drug reactions (SADRs) were analyzed in a prospective…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Nocturnal hypertension in primary care patients with high office blood pressure: A regional study of the MAPAGE project by Zabawa, Claire, Charra, Clément, Waldner, Anne, Morel, Gilles, Zeller, Marianne, Guilloteau, Adrien, Mazalovic, Katia

    “…Nocturnal hypertension (NH) is an independent cardiovascular risk factor. We aimed to describe the frequency of NH among primary care hypertensive patients and…”
    Get full text
    Journal Article
  5. 5

    Duration of first-line antiretroviral therapy in HIV-infected treatment-naive patients in routine practice by Tesson, Thomas, Blot, Mathieu, Fillion, Aurélie, Djerad, Hama, Cagnon-Chapalain, Joséphine, Creuwels, Aline, Waldner, Anne, Duong, Michel, Buisson, Marielle, Mahy, Sophie, Chavanet, Pascal, Piroth, Lionel

    Published in Antiviral therapy (01-01-2016)
    “…First-line antiretroviral therapy (1st ART) is an important step in a patient's management and often considered a long-term therapy at treatment initiation. To…”
    Get more information
    Journal Article
  6. 6

    Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? by PIROTH, L, DUONG, M, CHAVANET, P, QUANTIN, C, ABRAHAMOWICZ, M, MICHARDIERE, R, AHO, L.-S, GRAPPIN, M, BUISSON, M, WALDNER, A, PORTIER, H

    Published in AIDS (London) (05-03-1998)
    “…To study the influence of hepatitis C virus (HCV) co-infection on clinical and immunological evolution of HIV-infected patients. A longitudinal study of…”
    Get full text
    Journal Article
  7. 7

    Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients by Chavanet, P, Lopez, J, Grappin, M, Bonnin, A, Duong, M, Waldner, A, Buisson, M, Camerlynck, P, Portier, H

    Published in AIDS (London) (01-07-1994)
    “…To investigate (1) the frequency of clinical resistance to oral polyenes or azole treatment for oral candidiasis, (2) the frequency of resistant in vitro…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin by Portier, H, Chavanet, P, Waldner-Combernoux, A, Kisterman, J P, Grey, P C, Ichou, F, Safran, C

    “…A total of 220 adults and children > 10 years old (mean 29.5 +/- 11.7 years) with pharyngitis/tonsillitis were randomized to receive either cefpodoxime…”
    Get more information
    Journal Article